Hydroxyzine Initiation Following Drug Safety Advisories on Cardiac Arrhythmias in the UK and Canada: A Longitudinal Cohort StudyDRUG SAFETYIF3.82022-04-191OAAI
Influence of drug safety advisories on drug utilisation: an international interrupted time series and meta-analysisBMJ QUALITY & SAFETYIF6.52022-01-206OAAI
Postmarket Safety Communication for Protection of Public Health: A Comparison of Regulatory Policy in Australia, Canada, the European Union, and the United StatesCLINICAL PHARMACOLOGY & THERAPEUTICSIF5.52020-10-1116OAAI
Moderating the impact of patent linkage on access to medicines: lessons from variations in South Korea, Australia, Canada, and the United StatesGLOBALIZATION AND HEALTHIF4.52018-10-2418OAAI
The International Decision Support Initiative Reference Case for Economic Evaluation: An Aid to ThoughtVALUE IN HEALTHIF62016-12-01200OAAI
Costs to Australian taxpayers of pharmaceutical monopolies and proposals to extend them in the Trans-Pacific Partnership AgreementMEDICAL JOURNAL OF AUSTRALIAIF8.52015-02-2315OAAI
Costs of New Treatments for Hepatitis C InfectionJAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATIONIF552014-11-262PREAI
Is there any evidence that the Trans Pacific Partnership Agreement will threaten access to affordable medicines and health equity in New Zealand? ReplyHEALTH POLICYIF3.42014-06-010PREAI
Transferability of results of cost utility analyses for biologicals in inflammatory conditions for Central and Eastern European countriesEUROPEAN JOURNAL OF HEALTH ECONOMICSIF32014-05-1612PREAI
Applying rapid 'de-facto' HTA in resource-limited settings: Experience from RomaniaHEALTH POLICYIF3.42013-10-0127PREAI
Biosimilars And The European Experience: Implications For The United StatesHEALTH AFFAIRSIF8.12013-10-0135PREAI
How the Trans Pacific Partnership Agreement could undermine PHARMAC and threaten access to affordable medicines and health equity in New ZealandHEALTH POLICYIF3.42013-10-0131OAAI
Intussusception Risk and Disease Prevention Associated With Rotavirus Vaccines in Australia's National Immunization ProgramCLINICAL INFECTIOUS DISEASESIF7.32013-08-19164OAAI
Australia's 'Fourth Hurdle' Drug Review Comparing Costs And Benefits Holds Lessons For The United StatesHEALTH AFFAIRSIF8.12013-04-0116PREAI
Simulated Value-Based Insurance Design Applied to Statin Use by Medicare Beneficiaries with DiabetesVALUE IN HEALTHIF62012-05-0113OAAI
Does Medication Adherence Lower Medicare Spending among Beneficiaries with Diabetes?HEALTH SERVICES RESEARCHIF3.22011-03-1739OAAI
TOWARDS AN INTEGRATED APPROACH TO THE ASSESSMENT OF SURROGATE OUTCOME DATAVALUE IN HEALTHIF62009-05-010OAAI